Minnesota SF 2671: Qualifying prescription drugs cost disclosure and report requirements

Status: Referred to Health and Human Services Finance and Policy (as of 2018-02-26)

State: Minnesota · Session: 2017-2018 · Bill: SF 2671

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Jensen, Draheim, Pratt, Wiklund

View Minnesota SF 2671 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.